Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)

CompletedOBSERVATIONAL
Enrollment

3,457

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Alpha-1 Antitrypsin DeficiencyChronic Obstructive Pulmonary Disease
Trial Locations (19)

10025

St. Luke's-Roosevelt Hospital Center, New York

27599

University of North Carolina at Chapel Hill, Chapel Hill

29425

Medical University of South Carolina, Charleston

30033

Atlanta VA Medical Center, Decatur

30308

Emory Crawford Long Hospital, Atlanta

30322

Emory University, Atlanta

32209

University of Florida (Jacksonville), Jacksonville

32610

University of Florida (Gainesville), Gainesville

33101

University of Miami, Miami

33125

Miami VA Medical Center, Miami

33332

Cleveland Clinic Florida, Weston

44195

The Cleveland Clinic Foundation, Cleveland

55905

Mayo Clinic Rochester, Rochester

60637

University of Chicago, Chicago

75708

University of Texas Health Science Center at Tyler, Tyler

80206

National Jewish Medical and Research Center, Denver

90095

University of California Los Angeles, Los Angeles

97239

Oregon Health & Science University, Portland

09036

San Juan City Hospital, Centro Medico Metropolitano

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alpha-1 Foundation

OTHER

NCT01419158 - Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter